Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hepatology
Alcohol-associated Liver Disease
Questions discussed in this category
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
1 Answer available
How do you approach a conversation with a patient with a markedly positive PETH (>200 ug/L) who is insistent that they do not consume any alcohol?
Do you perform any subsequent testing?
1 Answer available
In what clinical scenario would larsucosterol be considered as therapy in alcohol related hepatitis?
1 Answer available
How do you balance infection risk versus therapeutic benefit of steroid tapers when treating patients with alcohol related hepatitis?
1 Answer available
How do you utilize the Sustained Alcohol Use Post-Liver Transplant (SALT) score on surveillance for alcohol use for patients after liver transplant?
1 Answer available
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
2 Answers available
23576
23579
23707
23708
23706
23705
Papers discussed in this category
Drug and alcohol dependence, 2024 Sep 07
Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.
JAMA psychiatry, 2025 Apr 01
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.
Related Topics in Hepatology
Gastroenterology
General Hepatology
Metabolic Dysfunction-Associated Liver Diseases
Viral Hepatitis
Autoimmune Liver Disease
Transplant Hepatology
Genetic Liver Disease
Portal Hypertension
Alcohol-associated Liver Disease
Liver Tumors